)
)
)
Quick-Fire Briefing: The Evolving Impact of the UPC on Pharmaceutical Patent Enforcement
Three years after its launch, the UPC has become a defining forum in pharmaceutical patent disputes, changing how rights holders approach cross-border enforcement and influencing decision-making well beyond Europe. As the Court continues to mature and its body of case law expands, companies are rethinking their litigation strategies in response to an evolving European framework with growing international significance. Delivering a sector-specific update on Europe's centralised patent court, this quick-fire briefing explores how the UPC has impacted pharmaceutical patent enforcement three years on, and what its continued evolution means for the sector.